Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.
Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a note clarifying that publications shown are automatically filled from PubMed and may not be about the study; updated the revision label to v3.3.2 and adjusted the corresponding deletion note to v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedThe government funding notice about potential data delays and NIH Clinical Center status has been removed; it previously warned that information might not be up to date and directed readers to cc.nih.gov and opm.gov for status updates.SummaryDifference0.3%
- Check43 days agoChange DetectedThe changes seem to be cosmetic UI/formatting adjustments with no alteration of core trial information (such as eligibility criteria, interventions, outcomes, or status). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%
- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
- Check93 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.